MSB 7.69% $1.19 mesoblast limited

The efficacy has never been a problem it is the safety that is...

  1. 13,390 Posts.
    lightbulb Created with Sketch. 576
    The efficacy has never been a problem it is the safety that is the problem, yes I get the short term effects are rare but FDA themselves say they have no idea on long term health impacts. For me at 34, I think I’m too young to gamble on potential long term health impacts - but if over 50’s prob worth it.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.